Delivery Order SPE2DB22D1002-SPE2DB25FLHT2
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,763.46 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 11, 2025. This firm fixed-price contract, awarded on August 8, 2025, represents a non-set-aside competitive procurement with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, valued at $7,053.84 with a firm fixed price structure. The contract was competitively awarded without set-aside designation and is scheduled for completion by July 23, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,758.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This firm fixed price contract was competitively awarded with no set-aside designation and is scheduled for completion by August 20, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $7,720.60 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $26,085.80 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement needs,...
- The Defense Logistics Agency awarded a $1,039.69 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 10, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive pharmaceutical supply agreement valued at $999,999,999.00 through December 2026. The contract will be performed at...
- The Defense Logistics Agency awarded a delivery order valued at $34,811.78 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on August 29, 2025, with completion scheduled for September 2, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The vaccine delivery will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $4,772.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $113K to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for M-M-R II vaccine vials valued at $15,329.48. This firm fixed-price contract, awarded on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a competitive award with no set-aside designation. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLHT2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,260.96 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of September 17, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance, which is also AmerisourceBergen's corporate headquarters location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical support vehicle extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA covering a wide spectrum of pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities. This specific vaccine procurement reflects AmerisourceBergen's ongoing role in supporting the Defense Health Agency and other federal healthcare systems through flexible contract vehicles that enable rapid fulfillment of medical supply requirements across the military healthcare enterprise.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 9/16/25 |